Navigating the complex landscape of benzodiazepine- and Z-drug diversity: insights from comprehensive FDA adverse event reporting system analysis and beyond

Navigating the complex landscape of benzodiazepine- and Z-drug diversity: insights from comprehensive FDA adverse event reporting system analysis and beyond

IntroductionMedications which target benzodiazepine (BZD) binding sites of GABAA receptors (GABAARs) have been in widespread use since the nineteen-sixties. They carry labels as anxiolytics, hypnotics or antiepileptics. All benzodiazepines and several nonbenzodiazepine Z-drugs share high affinity bi...

Full description

Bibliographic Details
Main Authors: Filip Koniuszewski, Florian D. Vogel, Irena Dajić, Thomas Seidel, Markus Kunze, Matthäus Willeit, Margot Ernst
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Psychiatry
Subjects:
Z-drugs
benzodiazepine binding sites
sex differences
adverse events
pharmacovigilance
side effects
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1188101/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1188101/full

Similar Items